More about

Interstitial Lung Disease

News
November 08, 2019
2 min read
Save

Top pulmonology news from October: ERS International Congress coverage, effects of e-cigarettes and more

Healio Pulmonology has you covered. The Editors have compiled a list of popular articles posted on Healio Pulmonology in October.

News
November 05, 2019
3 min read
Save

Inhaled nitric oxide improves exercise capacity in patients at risk for pulmonary fibrosis-related pulmonary hypertension

NEW ORLEANS — Patients with pulmonary fibrosis who are at risk for pulmonary hypertension experienced improvements in physical activity after treatment with inhaled nitric oxide, according to a study presented at the CHEST Annual Meeting.

News
October 17, 2019
2 min read
Save

Study lays groundwork for understanding RA-ILD/RA-IPF overlap

Comparative serum protein biomarker profiling may allow researchers to identify patients with rheumatoid arthritis-associated interstitial lung disease and/or idiopathic pulmonary fibrosis, according to findings published in Arthritis Rheumatology.

News
October 10, 2019
1 min read
Save

Nintedanib receives FDA breakthrough designation for chronic fibrosing ILD

Boehringer Ingelheim announced that the FDA has granted nintedanib breakthrough therapy designation for chronic fibrosing interstitial lung disease with a progressive phenotype, according to a press release.

News
October 03, 2019
4 min read
Save

Pirfenidone promising for unclassifiable ILD

Pirfenidone treatment was associated with improvement in several outcomes among patients with progressive fibrosing unclassifiable interstitial lung disease, according to a new study.

News
October 01, 2019
4 min read
Save

INBUILD: Nintedanib slows progression of fibrosing ILD

INBUILD: Nintedanib slows progression of fibrosing ILD

When compared with placebo, nintedanib slowed the annual rate of decline in FVC in patients with progressive fibrosing interstitial lung disease other than idiopathic pulmonary fibrosis, researchers reported at the European Respiratory Society International Congress.

News
September 24, 2019
1 min read
Save

Five FDA news stories you may have missed

In September, the FDA approved the first treatment for a rare pulmonary disease, issued warnings for patients, providers and manufacturers and stepped up its efforts to investigate the outbreak of lung injuries related to the use of electronic cigarettes.

News
September 13, 2019
1 min read
Save

FDA warns breast cancer treatments may lead to rare but severe lung inflammation

The FDA issued a safety alert today indicating that three drugs used to treat some patients with advanced breast cancer may cause rare but severe lung inflammation.

News
September 06, 2019
1 min read
Save

FDA approves nintedanib for systemic sclerosis-associated ILD

The FDA has approved nintedanib capsules to slow the rate of decline in pulmonary function in adults with interstitial lung disease associated with systemic sclerosis or scleroderma, according to a press release.

View more